Cargando…

FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR

The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weigh...

Descripción completa

Detalles Bibliográficos
Autores principales: Nair, Anroop B, Gupta, Rachna, Kumria, Rachna, Jacob, Shery, Attimarad, Mahesh
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979213/
https://www.ncbi.nlm.nih.gov/pubmed/24825991
_version_ 1782310711068721152
author Nair, Anroop B
Gupta, Rachna
Kumria, Rachna
Jacob, Shery
Attimarad, Mahesh
author_facet Nair, Anroop B
Gupta, Rachna
Kumria, Rachna
Jacob, Shery
Attimarad, Mahesh
author_sort Nair, Anroop B
collection PubMed
description The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weight gain using opadry®. Enteric coating was carried out using different polymers like Eudragit L-30 D-55, hydroxy propyl methylcellulose phthalate, cellulose acetate phthalate and Acryl-EZE® to achieve 5% weight gain. Disintegration studies showed that the formulations failed in 0.1 N HCl media. Hence the quantity of enteric coating was increased to 8% w/w. In vitro analysis of the developed tablets was carried out. Results from disintegration time and dissolution rate studies indicate that all the esomeprazole enteric tablets prepared possess good integrity, desirable for enteric coated tablets. Among the polymers studied, the methacrylic polymers exhibited better dissolution rate than the cellulose polymers. Stability studies indicate that the prepared formulations were stable for a period of three months. This study concluded that enteric coated tablets of esomeprazole can be prepared using any of the enteric coating polymer studied using a minimal weight gain of 8%.
format Online
Article
Text
id pubmed-3979213
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-39792132014-05-13 FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR Nair, Anroop B Gupta, Rachna Kumria, Rachna Jacob, Shery Attimarad, Mahesh J Basic Clin Pharm Original Article The present study was an attempt to formulate and evaluate enteric coated tablets for esomeprazole magnesium trihydrate. Different core tablets were prepared and formulation (F-1) was selected for further enteric coating, based on the disintegration time. Seal coating was applied to achieve 3% weight gain using opadry®. Enteric coating was carried out using different polymers like Eudragit L-30 D-55, hydroxy propyl methylcellulose phthalate, cellulose acetate phthalate and Acryl-EZE® to achieve 5% weight gain. Disintegration studies showed that the formulations failed in 0.1 N HCl media. Hence the quantity of enteric coating was increased to 8% w/w. In vitro analysis of the developed tablets was carried out. Results from disintegration time and dissolution rate studies indicate that all the esomeprazole enteric tablets prepared possess good integrity, desirable for enteric coated tablets. Among the polymers studied, the methacrylic polymers exhibited better dissolution rate than the cellulose polymers. Stability studies indicate that the prepared formulations were stable for a period of three months. This study concluded that enteric coated tablets of esomeprazole can be prepared using any of the enteric coating polymer studied using a minimal weight gain of 8%. Medknow Publications & Media Pvt Ltd 2010-09 2010-11-15 /pmc/articles/PMC3979213/ /pubmed/24825991 Text en Copyright: © Journal of Basic and Clinical Pharmacy http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Article
Nair, Anroop B
Gupta, Rachna
Kumria, Rachna
Jacob, Shery
Attimarad, Mahesh
FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title_full FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title_fullStr FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title_full_unstemmed FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title_short FORMULATION AND EVALUATION OF ENTERIC COATED TABLETS OF PROTON PUMP INHIBITOR
title_sort formulation and evaluation of enteric coated tablets of proton pump inhibitor
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3979213/
https://www.ncbi.nlm.nih.gov/pubmed/24825991
work_keys_str_mv AT nairanroopb formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor
AT guptarachna formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor
AT kumriarachna formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor
AT jacobshery formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor
AT attimaradmahesh formulationandevaluationofentericcoatedtabletsofprotonpumpinhibitor